Abstract

Protein-based therapies promise to treat everything from cancer to arthritis, but the bacteria and mammalian cells that usually produce proteins leave much to be desired. New research shows that green algae—and genetically tweaked yeast—can churn out proteins that are cheaper and better tailored for human use than those made by traditional systems. Amber Dance reports on these new recruits in the pharma factory.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call